Pediatric Cancers | Topics

 
Jackelyn B. Payne, MPH, MA, on Fertility Preservation in AYAs with Cancer
December 15, 2020

Payne and colleagues indicated that a significant number of adolescent and young adult women are still not being given the information they desire regarding fertility preservation and therefore are not making fully informed treatment decisions.

FDA Grants Accelerated Approval to Naxitamab-gqgk Combo for the Treatment of Neuroblastoma
November 30, 2020

The FDA granted accelerated approval to naxitamab-gqgk (Danyelza) in combination with GM-CSF for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.

Radiation May Cause Body Composition Abnormalities in Adult Survivors of Pediatric Cancer
October 01, 2020

A study found that radiation therapy to treat childhood abdominal and pelvic cancers potentially caused body composition abnormalities and worse cardiometabolic health for adult survivors compared to the general public.

Researchers Receive Grant to Initiate Study of ‘Chemo Brain’ in Pediatric Patients
September 02, 2020

This study is intended to “investigate how chemotherapy disrupts sensory processing, memory, and attention in children; where in the brain the damage is occurring; and whether there is a biomarker that can identify those who are most vulnerable.”

Impact of Radiation Therapy on Survivors of Pediatric Abdominal and Pelvic Tumors
August 28, 2020

This study found that abdominal or pelvic radiotherapy was associated with body composition changes that can adversely influence metabolic outcomes and performance status in survivors of abdominal or pelvic tumors.

Severe Hearing Impairment in Childhood Cancer Survivors May Be Linked to Neurocognitive Deficits
August 13, 2020

Study findings suggested that survivors with severe hearing loss are at a significantly increased risk for neurocognitive deficits, independent of what type of therapy they receive.

FDA Issues Complete Response Letter for Sodium Thiosulfate
August 11, 2020

A complete response letter was issued to Fennec Pharmaceuticals regarding the new drug application for a unique formulation of sodium thiosulfate (Pedmark).

Breast Cancer Screening With MRI for Survivors of Childhood Cancer
August 07, 2020

Jennifer M. Yeh, PhD, spoke about study findings which indicated that instituting annual breast cancer screening with MRI at ages 25 to 30 years may reduce breast cancer mortality by 50% or more in survivors of childhood cancer.

Earlier Breast Screening May Reduce Mortality in Survivors of Childhood Cancer
July 23, 2020

These findings suggested that instituting annual breast cancer screening with MRI earlier may reduce breast cancer mortality by at least 50% in survivors of childhood cancer.

Religion and Spirituality in AYAs with Cancer May Be Associated with Psychosocial Issues
July 22, 2020

These results indicated the necessity for providers to address the concerns of AYAs with cancer, including those of a spiritual nature.